Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsCirculating microRNAs: potential biomarkers for common malignanciesMinireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Dampening enthusiasm for circulating microRNA in breast cancer.Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patientsmiR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.Plasma microRNA panel for minimally invasive detection of breast cancerRegulation of cancer metastasis by cell-free miRNAs.Influence of plasma processing on recovery and analysis of circulating nucleic acids.Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.miRNA - Therapeutic tool in breast cancer? Where are we now?Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patientsMicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.Analysis of miRNA expression profiles in breast cancer using biclustering.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyCirculating microRNAs - a new horizon in molecular diagnosis of breast cancer.The Roles of MicroRNAs in Breast CancerThe effects of low-level laser irradiation on breast tumor in mice and the expression of Let-7a, miR-155, miR-21, miR125, and miR376b.A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.Controlled ovarian hyperstimulation induced changes in the expression of circulatory miRNA in bovine follicular fluid and blood plasma.MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.Prediction of miRNA-disease associations with a vector space modelSerum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.Plasma exosome microRNAs are indicative of breast cancer.MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.Targeting MicroRNAs in Cancer Gene Therapy.
P2860
Q26775086-20213347-5C1C-48F4-9790-0B6B88BD14A6Q26825022-2CD1A3CB-EB51-4098-A933-1CD6816DD559Q28081347-2E88AFF5-7E4A-4215-A2F6-6507D1228CC2Q33635886-67632862-903A-4256-8B61-7D6485F01CEEQ33823829-F7A0566D-6AE0-40BC-A37B-1C23314C365EQ33864278-F86BCE16-04E8-4F5E-86C1-F8C02E5643FFQ33916362-33209D93-6D7C-4EA3-977B-2A5E288D004FQ34221705-E859DBFD-048C-479C-AAD1-10317A2A9AFFQ34324137-26772C5C-4419-4A0C-BB5C-16F12BD57AF5Q34426839-EC094FCB-472A-4CFD-A803-B07B87F800E0Q34599354-EA19CEC0-F8D6-4370-81E8-640C1927E77EQ34614489-7ED140AE-2FEB-4E8E-9FCF-26A164DF72D9Q34654554-9608EB8E-B3F2-4EA4-945F-072235F89884Q35009302-5EFC92C6-941B-4B06-86B3-DB2DA95A5110Q35032320-25E559E0-C089-4D04-8B45-374C64500543Q35034340-615E5096-6420-4CEB-8E6B-2AB03CC0D3DCQ35035846-33165C6F-5482-4BBF-8C85-8BB0A4BE1B82Q35055089-33D14651-C2A8-4082-ACD0-F0567B720CE6Q35082591-DC264EE5-FE78-4651-A20C-7BC42FD0E532Q35094742-98766749-DAE2-4FB2-9AB1-4DB527138DEEQ35113386-1212FBF7-DCA5-48CF-8094-43643CB2E732Q35120108-0B21F82B-B255-41D5-BC8C-9CF37135FA34Q35123674-74782E16-59FE-47EA-948B-1F59869FAFB1Q35141171-EABFD3F7-EAB3-4A09-86E6-154FFAA14E73Q35203556-2E03D96E-5807-408D-81AF-FCDBFDC7A7C8Q35543094-B1EE986D-7CE1-4551-93C7-93ECD781F79DQ35786673-970C7128-49E1-4FED-8EA7-DFD331D024E4Q35818407-437A0D95-498A-472E-948B-5A3F0D335ECFQ36102632-5A6843D1-2C65-463E-B289-F8AE071D6530Q36212307-2D7CEFFC-88FF-4B36-BF4A-C322A36C0117Q36357957-550DCFAF-962C-4680-9D0E-4D3350025E65Q36727107-9DF2FD89-9E8D-4105-AE7A-C5A7E0D35390Q36829811-6006C12E-09C4-4CB2-8270-94556E77A352Q36939358-AAE350EF-4072-4B38-AE5F-74102E46C768Q36953740-E32A7CDF-72A6-489B-A58A-460F410E5A55Q36997902-4F89AB91-314C-4C75-852E-07D5C2401DFCQ37243591-AA9EE793-82C2-4A90-8E4C-B1A8CC172BFFQ37317467-55B4943F-1A15-46E0-9E67-CD97AE1E9F1CQ37451898-4ED53C97-2D1E-4683-B6DA-2E3F51F031BCQ37628264-5D0EFB0B-BD91-4D83-BC70-D49846CC201E
P2860
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Expression profiling of cancer ...... cancer and healthy volunteers
@ast
Expression profiling of cancer ...... cancer and healthy volunteers
@en
Expression profiling of cancer ...... cancer and healthy volunteers
@en-gb
Expression profiling of cancer ...... cancer and healthy volunteers
@nl
type
label
Expression profiling of cancer ...... cancer and healthy volunteers
@ast
Expression profiling of cancer ...... cancer and healthy volunteers
@en
Expression profiling of cancer ...... cancer and healthy volunteers
@en-gb
Expression profiling of cancer ...... cancer and healthy volunteers
@nl
prefLabel
Expression profiling of cancer ...... cancer and healthy volunteers
@ast
Expression profiling of cancer ...... cancer and healthy volunteers
@en
Expression profiling of cancer ...... cancer and healthy volunteers
@en-gb
Expression profiling of cancer ...... cancer and healthy volunteers
@nl
P2093
P2860
P3181
P356
P1476
Expression profiling of cancer ...... cancer and healthy volunteers
@en
P2093
Dieter J Peeters
Eleni van Schooneveld
Hans Wildiers
Ilse Van der Auwera
Luc Y Dirix
Maartje Ca Wouters
Peter A Van Dam
Peter B Vermeulen
Steven J Van Laere
P2860
P2888
P3181
P356
10.1186/BCR3127
P407
P577
2012-01-01T00:00:00Z
P5875
P6179
1049102770